Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib
作者： Antoine Italiano , Angela Cioffi , Paola Coco , Robert G. Maki , Patrick Schöffski
DOI: 10.1245/S10434-011-2120-6
关键词:
摘要: Background Data regarding the management and outcome of patients with metastatic gastrointestinal stromal tumors (GIST) refractory to 1st-line imatinib 2nd-line sunitinib are limited.
springer.com
elsevier.com
cshl.edu
sci-hub.se 参考文章(27)
Lauri A. Aaltonen, Stanley R. Hamilton, Pathology and genetics of tumours of the digestive system IARC Press. ,(2000)
Isabelle Hostein, Nicolas Faur, Charlotte Primois, Frédérique Boury, Jérome Denard, Jean-François Emile, Pierre-Paul Bringuier, Jean-Yves Scoazec, Jean-Michel Coindre, BRAF Mutation Status in Gastrointestinal Stromal Tumors American Journal of Clinical Pathology. ,vol. 133, pp. 141- 148 ,(2010) , 10.1309/AJCPPCKGA2QGBJ1R
Akira Sawaki, Toshirou Nishida, Toshihiko Doi, Yasuhide Yamada, Yoshito Komatsu, Tatsuo Kanda, Yoshihiro Kakeji, Yusuke Onozawa, Makoto Yamasaki, Atsushi Ohtsu, Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor Cancer. ,vol. 117, pp. 4633- 4641 ,(2011) , 10.1002/CNCR.26120
Hans Prenen, Gunther Guetens, Gert de Boeck, Maria Debiec-Rychter, Paul Manley, Patrick Schöffski, Allan T. van Oosterom, Ernst de Bruijn, Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines Pharmacology. ,vol. 77, pp. 11- 16 ,(2006) , 10.1159/000091943
S. George, J.Y. Blay, P.G. Casali, A. Le Cesne, P. Stephenson, S.E. DePrimo, C.S. Harmon, C.N.J. Law, J.A. Morgan, I. Ray-Coquard, V. Tassell, D.P. Cohen, G.D. Demetri, Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure. European Journal of Cancer. ,vol. 45, pp. 1959- 1968 ,(2009) , 10.1016/J.EJCA.2009.02.011
Maria A. Pantaleo, Annalisa Astolfi, Monica Di Battista, Michael C. Heinrich, Paola Paterini, Katia Scotlandi, Donatella Santini, Fausto Catena, Maria C. Manara, Margherita Nannini, Alessandra Maleddu, Maristella Saponara, Cristian Lolli, Serena Formica, Guido Biasco, Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target International Journal of Cancer. ,vol. 125, pp. 2991- 2994 ,(2009) , 10.1002/IJC.24595
M. Montemurro, P. Schöffski, P. Reichardt, H. Gelderblom, J. Schütte, J.T. Hartmann, R. von Moos, B. Seddon, H. Joensuu, C.M. Wendtner, E. Weber, V. Grünwald, A. Roth, S. Leyvraz, Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib European Journal of Cancer. ,vol. 45, pp. 2293- 2297 ,(2009) , 10.1016/J.EJCA.2009.04.030
Scott Wilhelm, Du-Shieng Chien, BAY 43-9006: preclinical data. Current Pharmaceutical Design. ,vol. 8, pp. 2255- 2257 ,(2002) , 10.2174/1381612023393026
Renuka Iyer, Gerald Fetterly, Amit Lugade, Yasmin Thanavala, Sorafenib: a clinical and pharmacologic review. Expert Opinion on Pharmacotherapy. ,vol. 11, pp. 1943- 1955 ,(2010) , 10.1517/14656566.2010.496453
SONJA E. STEIGEN, TOR J. EIDE, BARTOSZ WASAG, JERZY LASOTA, MARKKU MIETTINEN, Mutations in gastrointestinal stromal tumors--a population-based study from Northern Norway. Apmis. ,vol. 115, pp. 289- 298 ,(2007) , 10.1111/J.1600-0463.2007.APM_587.X